HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
pyrisulfoxin A
isolated from Streptomyces califonicus; structure in first source
Networked:
1
relevant articles (
1
outcomes,
1
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyridines: 88
pyrisulfoxin A: 1
Organic Chemicals: 133
Sulfur Compounds: 278
Sulfoxides: 23
pyrisulfoxin A: 1
Experts
1.
Bae, Jong-Sup
: 1 article (09/2019)
2.
Choi, Hyukjae
: 1 article (09/2019)
3.
Kim, Eonmi
: 1 article (09/2019)
4.
Ku, Sae-Kwang
: 1 article (09/2019)
5.
Lee, Wonhwa
: 1 article (09/2019)
Related Diseases
1.
Lung Injury
09/01/2019 - "
These data suggested that collismycin C and pyrisulfoxin A might exert protective effects on PM-induced inflammatory lung injury and vascular hyperpermeability.
"
09/01/2019 - "
To confirm the inhibitory effects of collismycin C and pyrisulfoxin A on PM2.5-induced pulmonary injury STUDY DESIGN: In this study, we investigated the beneficial effects of collismycin C and pyrisulfoxin A on PM-induced lung endothelial cell (EC) barrier disruption and pulmonary inflammation.
"
09/01/2019 - "
Inhibitory effects of collismycin C and pyrisulfoxin A on particulate matter-induced pulmonary injury.
"
2.
Pneumonia (Pneumonitis)
09/01/2019 - "
To confirm the inhibitory effects of collismycin C and pyrisulfoxin A on PM2.5-induced pulmonary injury STUDY DESIGN: In this study, we investigated the beneficial effects of collismycin C and pyrisulfoxin A on PM-induced lung endothelial cell (EC) barrier disruption and pulmonary inflammation.
"
Related Drugs and Biologics
1.
collismycin C
2.
Particulate Matter